Abstract
Aims: Coronary artery disease (CAD) negatively affects prognosis in patients undergoing surgical aortic valve replacement, being currently evaluated in the most common used risk score. Our meta-analysis aims to clarify the prognostic role of CAD on mid-term survival in patients undergoing TAVI.
Methods and results: Studies reporting multivariate predictors of adverse outcomes in patients undergoing TAVI were systematically searched for and pooled, when appropriate, using a random-effect method. 960 citations were first screened and finally 7 studies (2472 patients) were included. Diagnosis of CAD was reported in 52%(42-65) of patients and 1169 Edwards SAPIEN and 1303 CoreValve prostheses were implanted. After a median follow up of 452 days (357-585) 24% of patients (19-33) died, and 23 (14-32) for cardiovascular death. At pooled analysis of multivariate approach, diagnosis of coronary artery disease did not increase risk of death (OR 1.0, 95% CI, confidence interval, 0.67-1.50 I-2 0%).
Conclusion: CAD does not affect mid-term TAVI outcome: this finding should be weighted to accurately evaluate risk and strategies for patients with severe aortic stenosis.
Original language | English |
---|---|
Pages (from-to) | 2528-2532 |
Number of pages | 5 |
Journal | International Journal of Cardiology |
Volume | 168 |
Issue number | 3 |
DOIs | |
Publication status | Published - 3 Oct 2013 |
Keywords
- TAVI
- CAD
- Mid-term outcomes
- HIGH-RISK PATIENTS
- SYSTEMATIC REVIEWS
- EJECTION FRACTION
- STENOSIS
- OUTCOMES
- REPLACEMENT
- IMPACT
- INTERVENTION
- MORTALITY
- REGISTRY